NKX2-1 and adenocarcinoma: Thyroid transcription factor-1 (TTF-1) is a marker of TRU-type adenocarcinoma[37,38], and two studies concerning 11 and 12 ALK-positive patients each revealed TTF-1 positivity in all ALK-positive adenocarcinomas[26,39].